3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Other solid neoplasm
1
Gynecologic
1
Gastrointestinal
1
Conditions
Breast Neoplasms
68
Neoplasms
32
Prostatic Neoplasms
30
Lung Neoplasms
24
Head and Neck Neoplasms
20
Neoplasm Metastasis
15
Motor Activity
14
Colorectal Neoplasms
14
Multiple Myeloma
13
Ovarian Neoplasms
11
Gastrointestinal Neoplasms
11
Fatigue
10
Carcinoma, Non-Small-Cell Lung
10
cyclopia sequence
8
Uterine Cervical Neoplasms
8
Pancreatic Neoplasms
8
Pain
8
Lymphoma
8
Anxiety Disorders
8
Smoking Cessation
7
Recurrence
7
Neoplasms, Plasma Cell
7
Esophageal Neoplasms
7
Endometrial Neoplasms
7
Carcinoma, Renal Cell
7
Tobacco Use Cessation
6
Rectal Neoplasms
6
Oropharyngeal Neoplasms
6
Leukemia
6
Depression
6
Interventions
Cisplatin
57
Pemetrexed
45
pembrolizumab
18
Nivolumab
15
Carboplatin
15
Gemcitabine
14
Cyclophosphamide
13
Radiotherapy
10
atezolizumab
8
Drug Therapy
8
Platinum
7
Ipilimumab
7
Doxorubicin
7
durvalumab
6
1,2-diaminocyclohexaneplatinum II citrate
6
tremelimumab
5
sodium thiosulfate
5
Vinorelbine
5
Radiotherapy, Intensity-Modulated
5
Interleukin-2
5
Chemotherapy, Adjuvant
5
Cerebral Decortication
5
sargramostim
4
fludarabine
4
defactinib
4
aldesleukin
4
tumor necrosis factor-alpha, CNGRC fusion protein, human
3
cediranib
3
Photochemotherapy
3
Neoadjuvant Therapy
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Mesothelioma, Malignant
×
Surveys and Questionnaires
×
Clear all
NCT01126346
2018-07-03
HOPE
Wake Forest University Health Sciences
Phase NA
Completed
10 enrolled